tirzepatide for short term weight loss Semaglutide vs. Tirzepatide causes more weight loss

The composite primary outcome death from CV causes, nonfatal MI, or nonfatal stroke occurred in a significantly lower percentage of patients in the empagliflozin group (10.5%) compared with the placebo group (12.1%

Br J Pharmacol 179:625641 Koob GF, Volkow ND (2010) Neurocircuitry of addiction

Combining liraglutide with metformin can be considered for patients with prior resistance to lifestyle and first-line reproductive treatments since data suggest improved IVF rates and spontaneous conception in some groups

PlexusDx can coordinate transition timing based on your treatment history and genetic profile to optimize appetite control throughout the switch

Research suggests that a significant proportion of weight lost on GLP-1 medications can be regained after stopping treatment

Aging (Albany NY)